Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
28%
OVERLAP
BY WEIGHT
16
# OF OVERLAPPING
HOLDINGS
BBP
65
HOLDINGS
26%
ALSO IN PBE
PBE
27
HOLDINGS
59%
ALSO IN BBP
SECTOR DRIFT (BBP minus PBE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 2.1% | 5.2% | 2.1% |
|
HALOZYME THERAPEUTICS INC | 2.1% | 3.2% | 2.1% |
|
TG THERAPEUTICS INC | 2.1% | 2.1% | 2.1% |
|
AMGEN INC | 2.0% | 5.1% | 2.0% |
|
PTC THERAPEUTICS INC | 1.8% | 2.7% | 1.8% |
BBP Overweight Relative to PBE
|
INTRA-CELLULAR THERAPIES INC | 2.6% |
|
BEIGENE LTD. SPONSORED ADR | 2.3% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 2.2% |
|
SAGE THERAPEUTICS INC | 2.2% |
|
AXSOME THERAPEUTICS, INC. | 2.1% |
|
SPRINGWORKS THERAPEUTICS, INC. | 2.1% |
|
BRIDGEBIO PHARMA, INC. | 1.9% |
|
ASCENDIS PHARMA A/S | 1.8% |
|
MADRIGAL PHARMACEUTICALS, INC. | 1.8% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | 1.7% |
BBP Underweight Relative to PBE
|
ILLUMINA INC | -5.8% |
|
ALNYLAM PHARMACEUTICALS INC | -5.7% |
|
ROYALTY PHARMA PLC CLASS A | -5.3% |
|
ANAVEX LIFE SCIENCES CORP. | -3.5% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.5% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -3.3% |
|
UNITED THERAPEUTICS CORP | -3.3% |
|
PROTAGONIST THERAPEUTICS, INC. | -3.1% |
|
AMGEN INC | -3.1% |
|
GILEAD SCIENCES INC | -3.1% |